Treatment-limiting renal tubulopathy in patients treated with tenofovir disoproxil fumarate

Lisa Hamzah, Frank A. Post(King's College Hospital NHS Foundation Trust), Simon I Hay(University of Washington), Michael Rayment(Chelsea and Westminster Hospital NHS Foundation Trust), John Booth(Great Ormond Street Hospital), Aseel Hegazi(Croydon University Hospital), Jeremy Levy(Imperial College Healthcare NHS Trust), Sophie José(NHS England), Rachael Jones(Chelsea and Westminster Hospital NHS Foundation Trust), David Chadwick(James Cook University Hospital), Caroline Sabin(Primary Health Care), Bruce M. Hendry, Deborah I. Williams, Margaret Johnson(Duke University), Angela Bailey(Imperial College Healthcare NHS Trust)
Journal of Infection
January 25, 2017
10.1016/j.jinf.2017.01.010
Cited by 56

Related Papers

The global distribution and burden of dengue
|Nature|2013|10.1k
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.8k
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.4k
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|6.7k
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k